Refine by
Next Generation Nanopore Sequencing Services In China
3 services found
by:Lucence Health Inc. based inPalo Alto, CALIFORNIA (USA)
HemeMARK™ is a next-generation sequencing assay that analyzes 45 cancer-related gene mutations in hematological malignancies including myeloid and lymphoid ...
Manufactured by:Elpiscience based inShanghai, CHINA
Elpiscience leverages our deep understanding of tumor biology and mechanisms of action to translate target biology for challenging pathways, develop biomarkers and strategically select indications and patients for clinical studies. We apply cutting-edge technologies including gene editing for target screening, single cell sequencing and advanced bioinformatics with over 1,000 tumor organoid ...
by:Lucence Health Inc. based inPalo Alto, CALIFORNIA (USA)
LiquidHALLMARK® is an ultrasensitive next-generation sequencing assay for genomic profiling of a patient’s unique cancer. By requiring only a single blood sample, LiquidHALLMARK provides important information for cancer care especially when tissue by invasive biopsy is insufficient or ...